Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0220723 (
PCA
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Reserpine (2.5 mg kg-1 i.p.) decreased rat brain 5-hydroxytryptamine (5-HT) by 86% 24 h later but most components of the 5-HT-dependent behavioural syndrome induced by p-chloroamphetamine (
PCA
, 5 mg kg-1 i.p.) or 5-methoxy-N,N-dimethyltryptamine (5-
MeODMT
, 5 mg kg-1 i.p.) over 1 h after administration were unaffected. However, Straub tail was increased after giving
PCA
or 5-
MeODMT
and head weaving was decreased after giving 5-
MeODMT
. 2. Frontal cortex extracellular 5-HT concentrations of vehicle pretreated rats before injection of
PCA
, as calculated from dialysate 5-HT concentrations, were about 1/1000th of corresponding brain values. Extracellular 5-hydroxyindoleacetic acid (5-HIAA) and brain values were comparable with each other. Dialysate 5-HT increased after
PCA
with peak values at 20-40 min. 3. Reserpine pretreatment reduced dialysate 5-HT concentration before
PCA
was given but the net increase (AUC) over the 1 h after
PCA
did not differ significantly from that seen in animals pretreated with vehicle. Dialysate 5-HIAA values slowly decreased after
PCA
injection in both reserpine and vehicle pretreated groups. 4. The results suggest that
PCA
causes the 5-HT syndrome by releasing 5-HT from the neuronal cytoplasm but that physiological release of 5-HT occurs from vesicular stores.
...
PMID:An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. 272 Mar 8
The effect of chronic corticosterone treatment (50 mg/kg s.c. 2 x daily) for up to 4 days on behavioural responses to drugs affecting 5-hydroxytryptamine (5-HT) and dopamine (DA) systems was examined in rats 20 h after the last treatment, when placed in experimental cages, to which they had become habituated. Corticosterone- and vehicle-treated rats exhibited both comparable spontaneous behavior when given 0.9% NaCl i.p. and showed similar behavioural responses following amphetamine (3 mg/kg i.p.). However, responses to the 5-HT-releasing drug p-chloroamphetamine (
PCA
, 4 mg/kg i.p.) were altered with decreased head-weaving hind-limb abduction and forepaw treading. Postsynaptic changes appear to be involved as responses to the 5-HT agonist 5-methoxy-N,N-dimethyltryptamine (5-
MeODMT
, 5 mg/kg i.p.) (tremor, hind-limb abduction and forepaw treading) were also decreased. Hind brain and striatal concentration of 5-HT, DA and their metabolites were comparable in corticosterone and vehicle treated rats killed 20 h after the last treatment. Brain
PCA
levels determined 30 min after injection were also comparable in both groups.
PCA
induced behaviour was not altered 20 h after 1 day corticosterone treatment or 4 day after 1 day treatment and 5-
MeODMT
-induced behaviour was not altered 20 h after 14 days treatment with a lower dose of corticosterone (10 mg/kg s.c. x 2). Twenty h after 1 day corticosterone treatment (50 mg/kg s.c. x 2), rats placed in an open field for the first time showed significantly more activity and dropped fewer faecal pellets than controls.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Reduced-5-hydroxytryptamine-dependent behavior in rats following chronic corticosterone treatment. 406 95